The focus of these grants is to contextualize the diagnosis and referral components of the national 'Optimal Cancer Care Pathways' on a local level.
Key information
- Status: Closed
- Grant amount: Up to $50,000
- Application opened: 25 July 2022
- Application closed: 2 September 2022, 5:00 pm
Program objective
The focus of these grants is to contextualise the diagnosis and referral components of the national ‘Optimal Cancer Care Pathways’ on a local level.
The methodology in the Cancer Care Pathways Toolkit, developed in partnership with the Cancer System Innovation Managers Community of Practice, must be used by projects in this grant.
Project work should be based on an integrated model of care within the clinical cancer community which will be reflected in the final product; a defined, localised diagnostic and referral pathway commencing with primary care that sits within the local version of Health Pathways or on an equivalent tool.
For this reason a collaborative approach across the Primary Health Network and Local Health District will be critical to the successful delivery of the project.
This program is funded and administered by Cancer Institute NSW.
Eligibility
Who can apply
The Innovations in Cancer Control Grants Program provides funding to
- Local Health Districts,
- Specialty Health Networks or
- Primary Health Networks.
These organisations will undertake evidence-based projects that have the potential to be embedded in the health system and are sustainable past the funding period.
The focus of these grants is service-centred initiatives; they are not for funding research projects.
Consideration will be given to applications which:
- assist health care professionals in transferring research outcomes into clinical practice
- build upon evidence which is currently available (for example, publications, previous
initiatives/projects, new optimal care pathways) - enhance cancer service provision by working towards the goals of the NSW Cancer Plan.
Funding
The funds must be spent for the primary purpose of achieving the objectives of the Innovations in Cancer Control Grants.
- All projects funded under the program will be required to report against evaluation measures developed by the applicants as part of the submission process.
- If a joint application is received and successful, funding will be provided to the lead applicant and distribution of funds is the lead applicant’s responsibility. This should be identified in the project budget to be submitted as part of the Application.
- The Institute reserves the right to award funds at a different level and for varying periods to that requested in the Application.
- Funding is not to be used for clinical service positions, provision of clinical services nor payment of medical officers/staff specialists/research fellows. Funding should be used to support the establishment of sustainable models of care/initiatives that can continue beyond the funding period. Please note that funding may be used to appoint a temporary project officer, or similar level position to undertake the project.
- As part of the final reporting requirements, a full financial acquittal verified by the organisation’s Chief Financial Officer is required.
- In addition to the Final Report, a summary document of the project outcomes, findings and learnings are also required to be submitted and this will be hosted on the Cancer Institute website.
- There is an expectation that successful applicants will participate in a relevant Communities of Practice group and submit an abstract to a conference held by the Cancer Institute NSW (or other agreed conference).
What can’t you apply for
The following items are out of scope for this grant round:
- capital purchases (including IT hardware or software)
- funding for research projects
- the continuation and/or evaluation of existing programs/initiatives
- funding for clinical service positions or the delivery of clinical services.
Please note, the funding may be used to appoint a fixed term project officer, or similar position (funding is not to be used for medical officers/staff specialists/research fellows) to undertake the project.
Most recent recipients
What your application needs to include
You can download the full guidelines:
Address the eligibility criteria
To be eligible for funding in the 2022 Grant Round:
- The organisation must be a Local Health District, Specialty Health Network or Primary Health Network.
- The organisation must be a GST registered organisation with a demonstrated track record in cancer control or vested interest in improving cancer outcomes for specific groups in the community and be based in and providing services to the population of NSW.
- Applicants must apply online via the Grants Management System (GMS).
- The project must commence in the 2022/23 financial year and be completed at the latest by 15 November 2024.
- All obligations regarding previously funded projects involving the applicants must have been fulfilled to the satisfaction of the Institute. Such obligations include the provision of satisfactory progress reports including budget update, final report including final budget and financial reconciliation report, and evaluation reports, submitted on time, as per the detailed project plan.
- The project must have an evaluation approach that includes both process measures and outcome measures. It is recommended that up to 10% of the total project cost is allocated to evaluation (an Evaluation Report template is included in the online Final Report submission for successful applicants).
- All applications must have the required signatures:
- Project Lead
- Project Sponsor
- Director of Cancer Services (for Local Health Districts and Specialty Health Networks) or equivalent (for Primary Health Networks), and
- Chief Executive (or equivalent).
- Applications with a partner organisation also require the signature of the appropriate authority from the partner organisation.
- A NSW Health Aboriginal Impact Statement (PD2017_034) will be required for successful grants to accompany the project plan.
Address the essential criteria
- The project identifies clinical leadership with subject matter expertise and a governance structure that includes input by and feedback to clinicians.
- Provision of a clear rationale for the proposed project initiative, including outlining what clinical variation has been identified (provide data) and how the clinical variation will be investigated.
- Provide a draft project plan and/or governance structure to outline how any identified unwarranted variation will be addressed.
- A) Provide an outline for how identified opportunities to improve the quality of systems and care will be approached, particularly when variation is not found to be unwarranted but opportunities for system change are identified; or
B) Provide an outline for how identified opportunities to address unwarranted variation (where confirmed) will be approached/actioned. - Commitment to working closely with the Institute to assess the opportunity to scale up successful projects statewide.
- Provision of a detailed final report in addition to a summary document of the completed project to facilitate knowledge sharing across the cancer system.
Address the assessment criteria
Each application will be reviewed and scored according to the project concept, including:
- sustainability
- project methodology
- project budget
- project evaluation
- experience/background
- focus and current activities of the organisation.
After the application is submitted
Successful applications will be decided by: Cancer Institute NSW’s Chief Executive Officer/Chief Cancer Officer.
The applications will be assessed and both successful and unsuccessful applicants will be notified.